Israel Chemicals Ltd. (ICL) Upgraded by Zacks Investment Research to “Strong-Buy”
Israel Chemicals Ltd. (NYSE:ICL) was upgraded by Zacks Investment Research from a “hold” rating to a “strong-buy” rating in a note issued to investors on Monday. The firm presently has a $4.25 target price on the stock. Zacks Investment Research’s target price points to a potential upside of 13.33% from the stock’s current price.
According to Zacks, “Israel Chemicals Ltd. is a manufacturer of specialty fertilizers and specialty phosphates, flame retardants and water treatment solutions. It operates primarily in three markets: agriculture, food and engineered materials. The Company’s products include bromine specialty chemicals, potash, phosphate fertilizers, and specialty performance and industrial products. It markets its products primarily in Israel, Europe, and the Americas. Israel Chemicals Ltd. is headquartered in Tel Aviv, Israel. “
Israel Chemicals (NYSE:ICL) remained flat at $3.75 on Monday. 79,677 shares of the stock were exchanged. Israel Chemicals has a 12-month low of $3.68 and a 12-month high of $5.86. The stock has a 50-day moving average price of $3.99 and a 200-day moving average price of $4.15. The stock has a market capitalization of $4.77 billion, a PE ratio of 11.83 and a beta of 1.10.
Israel Chemicals (NYSE:ICL) last announced its earnings results on Wednesday, August 10th. The company reported $0.10 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.06 by $0.04. The firm had revenue of $1.38 billion for the quarter, compared to the consensus estimate of $1.26 billion. Israel Chemicals had a return on equity of 17.44% and a net margin of 7.40%. The business’s quarterly revenue was up 15.1% compared to the same quarter last year. During the same period in the previous year, the business earned $0.08 EPS. On average, equities analysts forecast that Israel Chemicals will post $0.33 earnings per share for the current year.
The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, September 27th. Stockholders of record on Tuesday, September 13th were given a $0.047 dividend. The ex-dividend date was Friday, September 9th. This is a positive change from Israel Chemicals’s previous quarterly dividend of $0.03. This represents a $0.19 annualized dividend and a dividend yield of 5.01%. Israel Chemicals’s dividend payout ratio (DPR) is 59.38%.
Several hedge funds and other institutional investors have recently bought and sold shares of the company. Aperio Group LLC raised its position in Israel Chemicals by 438.4% in the first quarter. Aperio Group LLC now owns 239,636 shares of the company’s stock valued at $1,028,000 after buying an additional 195,126 shares during the period. JPMorgan Chase & Co. raised its position in Israel Chemicals by 56.5% in the first quarter. JPMorgan Chase & Co. now owns 357,335 shares of the company’s stock valued at $1,533,000 after buying an additional 129,051 shares during the period. Canada Pension Plan Investment Board raised its position in Israel Chemicals by 19.6% in the first quarter. Canada Pension Plan Investment Board now owns 1,487,570 shares of the company’s stock valued at $6,469,000 after buying an additional 243,400 shares during the period. Edmond DE Rothschild Holding S.A. raised its position in Israel Chemicals by 74.7% in the first quarter. Edmond DE Rothschild Holding S.A. now owns 147,805 shares of the company’s stock valued at $641,000 after buying an additional 63,205 shares during the period. Finally, AMP Capital Investors Ltd raised its position in Israel Chemicals by 13.9% in the first quarter. AMP Capital Investors Ltd now owns 398,097 shares of the company’s stock valued at $1,748,000 after buying an additional 48,637 shares during the period. 6.88% of the stock is owned by hedge funds and other institutional investors.
Receive News & Stock Ratings for Israel Chemicals Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Israel Chemicals Ltd. and related stocks with our FREE daily email newsletter.